Guardian Pharmacy Services Inc’s recent filing unveils that its Director BINDLEY WILLIAM E unloaded Company’s shares for reported $70.74 million on May 27 ’25. In the deal valued at $20.16 per share,3,508,905 shares were sold. As a result of this transaction, BINDLEY WILLIAM E now holds 2,591,271 shares worth roughly $52.68 million.
Then, BINDLEY WILLIAM E sold 651,454 shares, generating $13,133,313 in total proceeds. Upon selling the shares at $20.16, the Director now owns 1,939,817 shares.
Before that, Salentine Thomas J Jr sold 3,508,905 shares. Guardian Pharmacy Services Inc shares valued at $70,739,525 were divested by the Director at a price of $20.16 per share. As a result of the transaction, Salentine Thomas J Jr now holds 2,591,271 shares, worth roughly $52.68 million.
Truist initiated its Guardian Pharmacy Services Inc [GRDN] rating to a Buy in a research note published on October 21, 2024; the price target was $22. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late October with a ‘”an Outperform”‘ rating.
Price Performance Review of GRDN
On Monday, Guardian Pharmacy Services Inc [NYSE:GRDN] saw its stock fall -1.55% to $20.33. Over the last five days, the stock has lost -4.51%. Guardian Pharmacy Services Inc shares have risen nearly 0.35% since the year began.
Levels Of Support And Resistance For GRDN Stock
The 24-hour chart illustrates a support level at 19.78, which if violated will result in even more drops to 19.23. On the upside, there is a resistance level at 20.92. A further resistance level may holdings at 21.52. The Relative Strength Index (RSI) on the 14-day chart is 34.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.79%. Stochastics %K at 9.38% indicates the stock is a buying.
